BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25655281)

  • 1. Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts.
    Wang X; Chu J; Wen CJ; Fu SB; Qian YL; Wo Y; Wang C; Wang DR
    Exp Cell Res; 2015 Mar; 332(2):202-11. PubMed ID: 25655281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.
    Wang X; Qian Y; Jin R; Wo Y; Chen J; Wang C; Wang D
    PLoS One; 2013; 8(2):e55899. PubMed ID: 23418473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad interacting protein 1 influences transforming growth factor-β
    Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
    J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
    Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
    Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of tetrandine on gene expression of collagen type I, collagen type III and TGF-beta1 in scar tissue's of rabbits ear].
    Zhou XL; Liu DW; Mao YG; Lü J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Nov; 29(6):406-12. PubMed ID: 24624876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
    Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
    Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway.
    Ji X; Tang Z; Shuai W; Zhang Z; Li J; Chen L; Cao J; Yin W
    Life Sci; 2019 Aug; 231():116674. PubMed ID: 31344427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor.
    Song R; Bian HN; Lai W; Chen HD; Zhao KS
    Braz J Med Biol Res; 2011 May; 44(5):402-10. PubMed ID: 21445528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
    Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
    Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
    Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
    Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
    Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
    Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
    Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
    Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
    J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts.
    Wei G; Xu Q; Liu L; Zhang H; Tan X; Zhang C; Han C; Guo Y; Han G; Zhang C
    Arch Dermatol Res; 2018 Oct; 310(8):615-623. PubMed ID: 30046895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
    Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
    Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lentiviral vector-mediated TRADD expression on the inhibition of hypertrophic scar formation.
    Yuan Y; Peng G; Kang X; Liu Y; Dai J; Wu H
    Exp Biol Med (Maywood); 2014 Dec; 239(12):1557-66. PubMed ID: 24962175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of SnoN in human hypertrophic scar fibroblasts and the mechanism of its participation in hypertrophic scar formation].
    Kuang F; Zhang Z; Chen B; Liu CL; Zhao YY; Xu ZR; Li XJ
    Zhonghua Shao Shang Za Zhi; 2017 Oct; 33(10):634-638. PubMed ID: 29056026
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
    Qian W; Li N; Cao Q; Fan J
    J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
    Wang X; Gao Z; Wu X; Zhang W; Zhou G; Liu W
    Pharm Biol; 2016 Jul; 54(7):1189-97. PubMed ID: 26135051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
    Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
    Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.